BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
Public ClinicalTrials.gov record NCT01873404. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is to assess the efficacy of Intravenous (IV) BG00010 (Neublastin) in improving pain in painful lumbar radiculopathy participants when administered 3 times per week for 1 week. The secondary objectives of this study in this study population are as follows: To explore the duration of the effect of BG00010 in improving pain; To explore the dose response curve on pain reduction; To assess the safety and tolerability of BG00010; To assess the serum exposure to BG00010.
Study identification
- NCT ID
- NCT01873404
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 183 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2013 (Type not available)
- Primary completion
- Mar 2015 (Actual)
- Completion
- Mar 2015 (Actual)
- Last update posted
- Sep 10, 2015
2013 – 2015
United States locations
- U.S. sites
- 25
- U.S. states
- 13
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85018 | — |
| Research Site | Fresno | California | 93710 | — |
| Research Site | Lomita | California | 90717 | — |
| Research Site | Long Beach | California | 90806 | — |
| Research Site | Pasadena | California | 91105 | — |
| Research Site | Fort Lauderdale | Florida | 33312 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | Sarasota | Florida | 34232 | — |
| Research Site | St. Petersburg | Florida | 33713 | — |
| Research Site | Sunrise | Florida | 33351 | — |
| Research Site | Tampa | Florida | 33606 | — |
| Research Site | Winter Park | Florida | 32789 | — |
| Research Site | Columbus | Georgia | 31904 | — |
| Research Site | Savannah | Georgia | 31406 | — |
| Research Site | Bloomington | Illinois | 61701 | — |
| Research Site | Chicago | Illinois | 60657 | — |
| Research Site | Evansville | Indiana | 47714 | — |
| Research Site | Overland Park | Kansas | 66210 | — |
| Research Site | Brockton | Massachusetts | 02301 | — |
| Research Site | Lincoln | Nebraska | 68521 | — |
| Research Site | Raleigh | North Carolina | 27612 | — |
| Research Site | Winston-Salem | North Carolina | 27103 | — |
| Research Site | Duncansville | Pennsylvania | 16635 | — |
| Research Site | San Antonio | Texas | 78731 | — |
| Research Site | Salt Lake City | Utah | 84106 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01873404, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 10, 2015 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01873404 live on ClinicalTrials.gov.